{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:21:19Z","timestamp":1791422479003,"version":"4.3.3"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR049794"],"award-info":[{"award-number":["AR049794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG13918"],"award-info":[{"award-number":["AG13918"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Central Arkansas Veteran's Healthcare System","award":["1I01BX000294"],"award-info":[{"award-number":["1I01BX000294"]}]},{"DOI":"10.13039\/100015317","name":"UAMS Translational Research Institute","doi-asserted-by":"crossref","award":["UL1 RR029884"],"award-info":[{"award-number":["UL1 RR029884"]}],"id":[{"id":"10.13039\/100015317","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008519","name":"UAMS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bone.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T17:15:48Z","timestamp":1402938948000},"page":"146-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency"],"prefix":"10.1016","volume":"66","author":[{"given":"Jinhu","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff D.","family":"Thostenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros C.","family":"Manolagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.06.006_bb0005","series-title":"Vitamin D","first-page":"497","article-title":"Modeling and remodeling: how bone cells work together","author":"Parfitt","year":"2005"},{"key":"10.1016\/j.bone.2014.06.006_bb0010","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"90","article-title":"Parathyroid hormone: synthesis, secretion, and action","author":"Brown","year":"2006"},{"key":"10.1016\/j.bone.2014.06.006_bb0015","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.06.006_bb0020","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-{kappa}B ligand gene expression via a distant transcriptional enhancer","volume":"26","author":"Fu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2014.06.006_bb0025","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.006_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2014.06.006_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.06.006_bb0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bone.2014.06.006_bb0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2014.06.006_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1359\/JBMR.041022","article-title":"RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts","volume":"20","author":"Wu","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0055","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2014.06.006_bb0060","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2014.06.006_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.06.006_bb0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2014.06.006_bb0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jsbmb.2006.12.020","article-title":"Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3","volume":"103","author":"Kim","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bone.2014.06.006_bb0080","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.00353-06","article-title":"Activation of receptor activator of NF-{kappa}B ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2014.06.006_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/en.2007-0734","article-title":"Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass","volume":"149","author":"Galli","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.006_bb0090","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1359\/JBMR.040604","article-title":"1 alpha,25 dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways","volume":"19","author":"Kondo","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S8756-3282(99)00214-8","article-title":"Localization of RANKL (Receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues","volume":"25","author":"Kartsogiannis","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.006_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10735-004-3839-1","article-title":"Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat","volume":"36","author":"Silvestrini","year":"2005","journal-title":"J Mol Histol"},{"key":"10.1016\/j.bone.2014.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1359\/jbmr.2001.16.8.1416","article-title":"Expression profiles of receptor activator of nuclear factor kappa B ligand, receptor activator of nuclear factor kappa B, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones","volume":"16","author":"Ikeda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0110","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2014.06.006_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.006_bb0120","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.006_bb0125","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.06.006_bb0130","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1074\/jbc.M112.441360","article-title":"Parathyroid hormone (PTH)\/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH","volume":"288","author":"Saini","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.006_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/JOE-10-0308","article-title":"Targeted ablation of the PTH\/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses","volume":"209","author":"Powell","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bone.2014.06.006_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/154405910708600404","article-title":"DMP1-targeted Cre expression in odontoblasts and osteocytes","volume":"86","author":"Lu","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bone.2014.06.006_bb0150","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1074\/jbc.M112.444190","article-title":"Suppression of autophagy in osteocytes mimics skeletal aging","volume":"288","author":"Onal","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.006_bb0155","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.006_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/me.2011-1149","article-title":"The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice","volume":"26","author":"Onal","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.bone.2014.06.006_bb0165","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/endo.140.10.7036","article-title":"A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo","volume":"140","author":"Grey","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.006_bb0170","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-011-0749-z","article-title":"RANKL\/RANK-beyond bones","volume":"89","author":"Hanada","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.bone.2014.06.006_bb0175","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","volume":"274","author":"O'Brien","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.006_bb0180","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO;2-X","article-title":"Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells","volume":"31","author":"Choi","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bone.2014.06.006_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2014.06.006_bb0190","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1359\/jbmr.2002.17.11.2068","article-title":"MLO-Y4 osteocyte-like cells support osteoclast formation and activation","volume":"17","author":"Zhao","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0195","doi-asserted-by":"crossref","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss","volume":"287","author":"Onal","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.06.006_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2008.07.001","article-title":"T cells potentiate PTH-induced cortical bone loss through CD40L signaling","volume":"8","author":"Gao","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.bone.2014.06.006_bb0205","doi-asserted-by":"crossref","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","article-title":"Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss","volume":"5","author":"Tawfeek","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.06.006_bb0210","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.06.006_bb0215","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1359\/jbmr.071025","article-title":"Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2","volume":"23","author":"Usui","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0220","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bone.2012.09.040","article-title":"In vitro and in vivo approaches to study osteocyte biology","volume":"54","author":"Kalajzic","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.006_bb0225","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.06.006_bb0230","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bone.2009.08.050","article-title":"Control of RANKL gene expression","volume":"46","author":"O'Brien","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.06.006_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.06.006_bb0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrendo.2013.179","article-title":"The role of estrogen and androgen receptors in bone health and disease","volume":"9","author":"Manolagas","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bone.2014.06.006_bb0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2009.11.006","article-title":"Osteocyte apoptosis and control of bone resorption following ovariectomy in mice","volume":"46","author":"Emerton","year":"2010","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214002154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:49:09Z","timestamp":1589244549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214002154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":49,"alternative-id":["S8756328214002154"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}